AKT1 and female reproductive organ cancer: Overall, we believe that the administration of Akt inhibitors such as AZD5363 allows the robust sensitization of gynecological cancer cell lines to doxorubicin by removing molecular roadblocks that would impede the induction of apoptosis; this effect, however, might not be limited to cells originating from these tissues.